Cytomegalovirus-associated haemophagocytic lymphohistiocytosis: A rare cause of febrile neutropenia during cancer chemotherapy

Kristin Bergmann, Hanne Elisabeth Højsgaard Møller, Olav Jonas Bergmann*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Febrile neutropenia (FN) is a common complication in patients with cancer during treatment with antineoplastic drugs. The initial cause is usually bacterial, and treatment of FN follows well-defined algorithms. We report a case of a 62-year-old patient with chronic lymphocytic leukaemia (CLL), who developed FN, which was unresponsive to both empirical antibacterial and empirical antifungal therapy. Surprisingly, a diagnosis of the life-threatening condition haemophagocytic lymphohistiocytosis (HLH) associated with cytomegalovirus (CMV) infection was made and treated successfully. CMV-associated HLH has not previously been described in patients with CLL treated with rituximab and bendamustine. It is concluded that HLH should be considered in patients with cancer with FN not responding to conventional antibiotic therapy.

OriginalsprogEngelsk
Artikelnummerbcr-2018-225592
TidsskriftBMJ Case Reports
Vol/bind2018
ISSN1757-790X
DOI
StatusUdgivet - 14. sep. 2018

Fingeraftryk Dyk ned i forskningsemnerne om 'Cytomegalovirus-associated haemophagocytic lymphohistiocytosis: A rare cause of febrile neutropenia during cancer chemotherapy'. Sammen danner de et unikt fingeraftryk.

Citationsformater